|
1. Richart RM: Cervical intraepithelial neoplasia. Pathol Annu 1973,
8:301-328.
2. Mitchell MF, Tortolero-Luna G, Wright T, Sarkar A, Richards-Kortum R,
Hong WK, Schottenfeld D: Cervical human papillomavirus infection
and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr
1996(21):17-25.
3. Traen K, Svane D, Kryger-Baggesen N, Bertelsen K, Mogensen O: Stage
Ib cervical cancer during pregnancy: planned delay in
treatment--case report. Eur J Gynaecol Oncol 2006, 27(6):615-617.
4. Proietto A: Gynaecological cancer surgery. Best Pract Res Clin Obstet
Gynaecol 2006, 20(1):157-172.
5. Gonzalez D, Hernandez E, Anderson L, Heller P, Atkinson BF: Clinical
Significance of a cervical cytologic diagnosis of atypical squamous
cells of undetermined significance. Favoring a reactive process or low
grade squamous intraepithelial lesion. J Reprod Med 1996,
41(10):719-723.
6. Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of
cancer cells in metastatic sites. Nat Rev Cancer 2002, 2(8):563-572.
7. Overall CM, Lopez-Otin C: Strategies for MMP inhibition in cancer:
innovations for the post-trial era. Nat Rev Cancer 2002, 2(9):657-672.
8. Dang CV: c-Myc target genes involved in cell growth, apoptosis, and
metabolism. Mol Cell Biol 1999, 19(1):1-11.
9. Straughn JM, Jr., Richter HE, Conner MG, Meleth S, Barnes MN:
Predictors of outcome in small cell carcinoma of the cervix--a case
series. Gynecol Oncol 2001, 83(2):216-220.
10. Zhang J, Jung K, Lein M, Kristiansen G, Rudolph B, Hauptmann S,
Schnorr D, Loening SA, Lichtinghagen R: Differential expression of
matrix metalloproteinases and their tissue inhibitors in human
primary cultured prostatic cells and malignant prostate cell lines.
Prostate 2002, 50(1):38-45.
11. Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME: Altered
expression of NM23, a gene associated with low tumor metastatic
potential, during adenovirus 2 Ela inhibition of experimental
metastasis. Cancer Res 1988, 48(22):6550-6554.
12. Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS,
Fodstad O: Levels of nm23 messenger RNA in metastatic malignant
melanomas: inverse correlation to disease progression. Cancer Res
1992, 52(21):6088-6091.
13. Howlett AR, Petersen OW, Steeg PS, Bissell MJ: A novel function for
the nm23-H1 gene: overexpression in human breast carcinoma cells
leads to the formation of basement membrane and growth arrest. J
Natl Cancer Inst 1994, 86(24):1838-1844.
14. Kantor JD, McCormick B, Steeg PS, Zetter BR: Inhibition of cell
motility after nm23 transfection of human and murine tumor cells.
Cancer Res 1993, 53(9):1971-1973.
15. Leone A, Flatow U, VanHoutte K, Steeg PS: Transfection of human
nm23-H1 into the human MDA-MB-435 breast carcinoma cell line:
effects on tumor metastatic potential, colonization and enzymatic
activity. Oncogene 1993, 8(9):2325-2333.
16. Ohba K, Miyata Y, Koga S, Kanda S, Kanetake H: Expression of
nm23-H1 gene product in sarcomatous cancer cells of renal cell
carcinoma: correlation with tumor stage and expression of matrix
metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and
c-erbB-2. Urology 2005, 65(5):1029-1034.
17. Chen SY, Wang XQ, Li XM, Chen YX, Wu CQ: [Expressions of P16 and
nm23-H1 in nasopharyngeal cacinoma and their clinical significance].
Di Yi Jun Yi Da Xue Xue Bao 2005, 25(3):342-344, 348.
18. Che GW, Zhou QH, Zhu W, Wang YP, Qin Y, Liu LX, Chen XH, Sun YL,
Sun ZF: [Molecular mechanism of reversing metastatic phenotype in
human high-metastatic large cell lung cancer cell line L9981 by
nm23-H1]. Ai Zheng 2005, 24(3):278-284.
19. Chen HY, Hsu CT, Lin WC, Tsai HD, Chang WC: Prognostic value of
nm23 expression in stage IB1 cervical carcinoma. Jpn J Clin Oncol
2001, 31(7):327-332.
20. Kogan EA, Shvets SI, Kovalenko VL, Soboleva Iu V: [Correlation of
proliferation, apoptosis, angiogenesis and metastasizing in various
histogenetic types of pulmonary cancer (an immunohistochemical
investigation)]. Arkh Patol 2004, 66(6):33-38.
21. Zheng CL, Wen JF, Huang Y: [Expression and significance of PTEN
and nm23 in the metastasis of gallbladder cancer]. Zhong Nan Da Xue
Xue Bao Yi Xue Ban 2005, 30(1):46-48.
22. Liu WK, Chu YL, Zhang F, Chen P, Cheng F, Wang H, Jia YY, Ma TY:
The relationship between HPV16 and expression of CD44v6, nm23H1
in esophageal squamous cell carcinoma. Arch Virol 2005,
150(5):991-1001.
23. Nosho K, Yamamoto H, Adachi Y, Endo T, Hinoda Y, Imai K: Gene
expression profiling of colorectal adenomas and early invasive
carcinomas by cDNA array analysis. Br J Cancer 2005,
92(7):1193-1200.
24. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AM:
Extracellular signal-regulated kinase (ERK)-dependent gene
expression contributes to L1 cell adhesion molecule-dependent
motility and invasion. J Biol Chem 2004, 279(28):28880-28888.
25. Lo CH, Lee SC, Wu PY, Pan WY, Su J, Cheng CW, Roffler SR, Chiang
BL, Lee CN, Wu CW et al: Antitumor and antimetastatic activity of
IL-23. J Immunol 2003, 171(2):600-607.
26. Zollo M, Andre A, Cossu A, Sini MC, D''Angelo A, Marino N, Budroni M,
Tanda F, Arrigoni G, Palmieri G: Overexpression of h-prune in breast
cancer is correlated with advanced disease status. Clin Cancer Res
2005, 11(1):199-205.
27. Chen XF, Zhang HT, Qi QY, Sun MM, Tao LY: Expression of
E-cadherin and nm23 is associated with the clinicopathological
factors of human non-small cell lung cancer in China. Lung Cancer
2005, 48(1):69-76.
28. Kao YR, Shih JY, Wen WC, Ko YP, Chen BM, Chan YL, Chu YW, Yang
PC, Wu CW, Roffler SR: Tumor-associated antigen L6 and the
invasion of human lung cancer cells. Clin Cancer Res 2003,
9(7):2807-2816.
29. Hemmerich S, Yarden Y, Pecht I: A cromoglycate binding protein from
rat mast cells of a leukemia line is a nucleoside diphosphate kinase.
Biochemistry 1992, 31(19):4574-4579.
30. Rosengard AM, Krutzsch HC, Shearn A, Biggs JR, Barker E, Margulies
IM, King CR, Liotta LA, Steeg PS: Reduced Nm23/Awd protein in
tumour metastasis and aberrant Drosophila development. Nature
1989, 342(6246):177-180.
31. Stahl JA, Leone A, Rosengard AM, Porter L, King CR, Steeg PS:
Identification of a second human nm23 gene, nm23-H2. Cancer Res
1991, 51(1):445-449.
32. Venturelli D, Martinez R, Melotti P, Casella I, Peschle C, Cucco C,
Spampinato G, Darzynkiewicz Z, Calabretta B: Overexpression of
DR-nm23, a protein encoded by a member of the nm23 gene family,
inhibits granulocyte differentiation and induces apoptosis in 32Dc13
myeloid cells. Proc Natl Acad Sci U S A 1995, 92(16):7435-7439.
33. Lombardi D, Lacombe ML, Paggi MG: nm23: unraveling its biological
function in cell differentiation. J Cell Physiol 2000, 182(2):144-149.
34. Mehus JG, Deloukas P, Lambeth DO: NME6: a new member of the
nm23/nucleoside diphosphate kinase gene family located on human
chromosome 3p21.3. Hum Genet 1999, 104(6):454-459.
35. Milon L, Rousseau-Merck MF, Munier A, Erent M, Lascu I, Capeau J,
Lacombe ML: nm23-H4, a new member of the family of human
nm23/nucleoside diphosphate kinase genes localised on chromosome
16p13. Hum Genet 1997, 99(4):550-557.
36. Munier A, Feral C, Milon L, Pinon VP, Gyapay G, Capeau J, Guellaen G,
Lacombe ML: A new human nm23 homologue (nm23-H5) specifically
expressed in testis germinal cells. FEBS Lett 1998, 434(3):289-294.
37. Tsuiki H, Nitta M, Furuya A, Hanai N, Fujiwara T, Inagaki M, Kochi M,
Ushio Y, Saya H, Nakamura H: A novel human nucleoside diphosphate
(NDP) kinase, Nm23-H6, localizes in mitochondria and affects
cytokinesis. J Cell Biochem 1999, 76(2):254-269.
38. Martinez R, Venturelli D, Perrotti D, Veronese ML, Kastury K, Druck T,
Huebner K, Calabretta B: Gene structure, promoter activity, and
chromosomal location of the DR-nm23 gene, a related member of the
nm23 gene family. Cancer Res 1997, 57(6):1180-1187.
39. Amendola R, Martinez R, Negroni A, Venturelli D, Tanno B, Calabretta B,
Raschella G: DR-nm23 gene expression in neuroblastoma cells:
relationship to integrin expression, adhesion characteristics, and
differentiation. J Natl Cancer Inst 1997, 89(17):1300-1310.
40. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO: The human
Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 2000,
32(3):247-258.
41. Sadek CM, Jimenez A, Damdimopoulos AE, Kieselbach T, Nord M,
Gustafsson JA, Spyrou G, Davis EC, Oko R, van der Hoorn FA et al:
Characterization of human thioredoxin-like 2. A novel
microtubule-binding thioredoxin expressed predominantly in the cilia
of lung airway epithelium and spermatid manchette and axoneme. JBiol Chem 2003, 278(15):13133-13142.
42. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS: Association of low nm23
RNA levels in human primary infiltrating ductal breast carcinomas
with lymph node involvement and other histopathological indicators
of high metastatic potential. Cancer Res 1989, 49(18):5185-5190.
43. Nakayama H, Yasui W, Yokozaki H, Tahara E: Reduced expression of
nm23 is associated with metastasis of human gastric carcinomas. Jpn
J Cancer Res 1993, 84(2):184-190.
44. Mandai M, Konishi I, Koshiyama M, Mori T, Arao S, Tashiro H, Okamura
H, Nomura H, Hiai H, Fukumoto M: Expression of metastasis-related
nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation
with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex
steroid receptor expression. Cancer Res 1994, 54(7):1825-1830.
45. Engel M, Theisinger B, Seib T, Seitz G, Huwer H, Zang KD, Welter C,
Dooley S: High levels of nm23-H1 and nm23-H2 messenger RNA in
human squamous-cell lung carcinoma are associated with poor
differentiation and advanced tumor stages. Int J Cancer 1993,
55(3):375-379.
46. Haut M, Steeg PS, Willson JK, Markowitz SD: Induction of nm23 gene
expression in human colonic neoplasms and equal expression in colon
tumors of high and low metastatic potential. J Natl Cancer Inst 1991,
83(10):712-716.
47. Myeroff LL, Markowitz SD: Increased nm23-H1 and nm23-H2
messenger RNA expression and absence of mutations in colon
carcinomas of low and high metastatic potential. J Natl Cancer Inst
1993, 85(2):147-152.
48. Nakamori S, Ishikawa O, Ohigashi H, Imaoka S, Sasaki Y, Kameyama M,
Kabuto T, Furukawa H, Iwanakga T, Kimura N: Clinicopathological
features and prognostic significance of nucleoside diphosphate
kinase/nm23 gene product in human pancreatic exocrine neoplasms.
Int J Pancreatol 1993, 14(2):125-133.
49. Zou M, Shi Y, al-Sedairy S, Farid NR: High levels of Nm23 gene
expression in advanced stage of thyroid carcinomas. Br J Cancer 1993,
68(2):385-388.
50. Tammenkoski M, Koivula K, Cusanelli E, Zollo M, Steegborn C, Baykov
AA, Lahti R: Human metastasis regulator protein H-prune is a
short-chain exopolyphosphatase. Biochemistry 2008, 47(36):9707-9713.
51. Garzia L, D''Angelo A, Amoresano A, Knauer SK, Cirulli C, Campanella
C, Stauber RH, Steegborn C, Iolascon A, Zollo M: Phosphorylation of
nm23-H1 by CKI induces its complex formation with h-prune and
promotes cell motility. Oncogene 2008, 27(13):1853-1864.
52. Marone M, Scambia G, Ferrandina G, Giannitelli C, Benedetti-Panici P,
Iacovella S, Leone A, Mancuso S: Nm23 expression in endometrial and
cervical cancer: inverse correlation with lymph node involvement and
myometrial invasion. Br J Cancer 1996, 74(7):1063-1068.
53. Blackburn EH: Structure and function of telomeres. Nature 1991,
350(6319):569-573.
54. Ishikawa F: [A review of the structure and function of human
telomere]. Tanpakushitsu Kakusan Koso 1996, 41(15 Suppl):2241-2253.
55. Blasco MA, Rizen M, Greider CW, Hanahan D: Differential regulation
of telomerase activity and telomerase RNA during multi-stage
tumorigenesis. Nat Genet 1996, 12(2):200-204.
56. Yashima K, Vuitch F, Gazdar AF, Fahey TJ, 3rd: Telomerase activity in
benign and malignant thyroid diseases. Surgery 1997,
122(6):1141-1145; discussion 1145-1146.
57. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams
RR, Chang E, Allsopp RC, Yu J et al: The RNA component of human
telomerase. Science 1995, 269(5228):1236-1241.
58. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I,
Robinson MO: A mammalian telomerase-associated protein. Science
1997, 275(5302):973-977.
59. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD,
Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q et al: hEST2, the
putative human telomerase catalytic subunit gene, is up-regulated in
tumor cells and during immortalization. Cell 1997, 90(4):785-795.
60. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH,
Lingner J, Harley CB, Cech TR: Telomerase catalytic subunit homologs
from fission yeast and human. Science 1997, 277(5328):955-959.
61. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing
of human fibroblasts. Nature 1990, 345(6274):458-460.
62. Greider CW: Telomere length regulation. Annu Rev Biochem 1996,
65:337-365.
63. Kyo S, Kanaya T, Ishikawa H, Ueno H, Inoue M: Telomerase activity in
gynecological tumors. Clin Cancer Res 1996, 2(12):2023-2028.
64. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey
DS: Telomerase activity: a prevalent marker of malignant human
prostate tissue. Cancer Res 1996, 56(1):218-222.
65. Bednarek AK, Sahin A, Brenner AJ, Johnston DA, Aldaz CM: Analysis of
telomerase activity levels in breast cancer: positive detection at the in
situ breast carcinoma stage. Clin Cancer Res 1997, 3(1):11-16.
66. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E,
Kajiyama G, Ide T: Telomerase activity in human liver tissues:
comparison between chronic liver disease and hepatocellular
carcinomas. Cancer Res 1995, 55(13):2734-2736.
67. Langford LA, Piatyszek MA, Xu R, Schold SC, Jr., Wright WE, Shay JW:
Telomerase activity in ordinary meningiomas predicts poor outcome.
Hum Pathol 1997, 28(4):416-420.
68. Chakravarti A, Delaney MA, Noll E, Black PM, Loeffler JS, Muzikansky
A, Dyson NJ: Prognostic and pathologic significance of quantitative
protein expression profiling in human gliomas. Clin Cancer Res 2001,
7(8):2387-2395.
69. Handra-Luca A, Bilal H, Bertrand JC, Fouret P: Extra-cellular
signal-regulated ERK-1/ERK-2 pathway activation in human salivary
gland mucoepidermoid carcinoma: association to aggressive tumor
behavior and tumor cell proliferation. Am J Pathol 2003,
163(3):957-967.
70. Olaussen KA, Dunant A, Fouret P, Brambilla E, Andre F, Haddad V,
Taranchon E, Filipits M, Pirker R, Popper HH et al: DNA repair by
ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant
chemotherapy. N Engl J Med 2006, 355(10):983-991.
71. Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N,
Chauhan D, Richardson P, Munshi NC, Anderson KC: Nuclear
factor-kappaB p65 mediates tumor necrosis factor alpha-induced
nuclear translocation of telomerase reverse transcriptase protein.
Cancer Res 2003, 63(1):18-21.
72. Liu K, Hodes RJ, Weng N: Cutting edge: telomerase activation in
human T lymphocytes does not require increase in telomerase reverse
transcriptase (hTERT) protein but is associated with hTERT
phosphorylation and nuclear translocation. J Immunol 2001,
166(8):4826-4830.
73. Nakano K, Watney E, McDougall JK: Telomerase activity and expression of telomerase RNA component and telomerase catalytic
subunit gene in cervical cancer. Am J Pathol 1998, 153(3):857-864.
74. Sagawa Y, Nishi H, Isaka K, Fujito A, Takayama M: The correlation of
TERT expression with c-myc expression in cervical cancer. Cancer
Lett 2001, 168(1):45-50.
75. Wisman GB, De Jong S, Meersma GJ, Helder MN, Hollema H, de Vries
EG, Keith WN, van der Zee AG: Telomerase in (pre)neoplastic cervical
disease. Hum Pathol 2000, 31(10):1304-1312.
76. Tsezou A, Oikonomou P, Kollia P, Mademtzis I, Kostopoulou E, Messinis
I, Vamvakopoulos N: The role of human telomerase catalytic subunit
mRNA expression in cervical dysplasias. Exp Biol Med (Maywood)
2005, 230(4):263-270.
77. Zhang A, Wang J, Zheng B, Fang X, Angstrom T, Liu C, Li X, Erlandsson
F, Bjorkholm M, Nordenskjord M et al: Telomere attrition
predominantly occurs in precursor lesions during in vivo carcinogenic
process of the uterine cervix. Oncogene 2004, 23(44):7441-7447.
78. Wang PH, Chang H, Ko JL, Lin LY: Nm23-H1 immunohistochemical
expression in multisteps of cervical carcinogenesis. Int J Gynecol
Cancer 2003, 13(3):325-330.
79. Ravazoula P, Aletra C, Kourounis G, Ladopoulos I, Tzigounis V:
Immunohistochemical analysis of nm23-H1 expression in human
cervical lesions. Eur J Gynaecol Oncol 2000, 21(5):510-512.
80. Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto
A, Bonifacio D, Di Bonito P, Paba P et al: Down-regulated nucleoside
diphosphate kinase nm23-H1 expression is unrelated to high-risk
human papillomavirus but associated with progression of cervical
intraepithelial neoplasia and unfavourable prognosis in cervical
cancer. J Clin Pathol 2006, 59(10):1044-1051.
81. Weber G: Enzymology of cancer cells (first of two parts). N Engl J Med
1977, 296(9):486-492.
82. Ohneda K, Fukuda M, Shimada N, Ishikawa N, Ichou T, Kaji K, Toyota T,
Kimura N: Increased expression of nucleoside diphosphate
kinases/nm23 in human diploid fibroblasts transformed by SV40
large T antigen or 60Co irradiation. FEBS Lett 1994, 348(3):273-277.
83. Pinto AP, Crum CP: Natural history of cervical neoplasia: defining
progression and its consequence. Clin Obstet Gynecol 2000,
43(2):352-362.
84. Bravaccini S, Sanchini MA, Amadori A, Medri L, Saragoni L, Calistri D,
Monti F, Volpi A, Amadori D: Potential of telomerase expression and
activity in cervical specimens as a diagnostic tool. J Clin Pathol 2005,
58(9):911-914.
85. Sarac E, Ayhan A, Ertoy D, Tuncer ZS, Yasui W, Tahara E: nm23
expression in carcinoma of the uterine cervix. Eur J Gynaecol Oncol
1998, 19(3):312-315.
86. Postel EH: Multiple biochemical activities of NM23/NDP kinase in
gene regulation. J Bioenerg Biomembr 2003, 35(1):31-40.
87. Malins DC, Polissar NL, Gunselman SJ: Progression of human breast
cancers to the metastatic state is linked to hydroxyl radical-induced
DNA damage. Proc Natl Acad Sci U S A 1996, 93(6):2557-2563.
88. Malins DC, Polissar NL, Schaefer S, Su Y, Vinson M: A unified theory
of carcinogenesis based on order-disorder transitions in DNA
structure as studied in the human ovary and breast. Proc Natl Acad
Sci U S A 1998, 95(13):7637-7642.
89. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR,
Vogelstein B, Kinzler KW: Gene expression profiles in normal and
cancer cells. Science 1997, 276(5316):1268-1272.
90. Pinon VP, Millot G, Munier A, Vassy J, Linares-Cruz G, Capeau J, Calvo
F, Lacombe ML: Cytoskeletal association of the A and B nucleoside
diphosphate kinases of interphasic but not mitotic human carcinoma
cell lines: specific nuclear localization of the B subunit. Exp Cell Res
1999, 246(2):355-367.
91. Yamashiro S, Urano T, Shiku H, Furukawa K: Alteration of nm23 gene
expression during the induced differentiation of human leukemia cell
lines. Oncogene 1994, 9(9):2461-2468.
92. Sager R: Expression genetics in cancer: shifting the focus from DNA
to RNA. Proc Natl Acad Sci U S A 1997, 94(3):952-955.
93. Sirotkovic-Skerlev M, Krizanac S, Kapitanovic S, Husnjak K, Unusic J,
Pavelic K: Expression of c-myc, erbB-2, p53 and nm23-H1 gene
product in benign and malignant breast lesions: coexpression and
correlation with clinicopathologic parameters. Exp Mol Pathol 2005,
79(1):42-50.
94. Valentijn LJ, Koppen A, van Asperen R, Root HA, Haneveld F, Versteeg
R: Inhibition of a new differentiation pathway in neuroblastoma by
copy number defects of N-myc, Cdc42, and nm23 genes. Cancer Res 2005, 65(8):3136-3145.
95. D''Angelo A, Garzia L, Andre A, Carotenuto P, Aglio V, Guardiola O,
Arrigoni G, Cossu A, Palmieri G, Aravind L et al: Prune cAMP
phosphodiesterase binds nm23-H1 and promotes cancer metastasis.
Cancer Cell 2004, 5(2):137-149.
96. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J: Tumor suppressor
NM23-H1 is a granzyme A-activated DNase during CTL-mediated
apoptosis, and the nucleosome assembly protein SET is its inhibitor.
Cell 2003, 112(5):659-672.
97. Forus A, D''Angelo A, Henriksen J, Merla G, Maelandsmo GM, Florenes
VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, del Vecchio Blanco F et
al: Amplification and overexpression of PRUNE in human sarcomas
and breast carcinomas-a possible mechanism for altering the
nm23-H1 activity. Oncogene 2001, 20(47):6881-6890.
98. Habets GG, Scholtes EH, Zuydgeest D, van der Kammen RA, Stam JC,
Berns A, Collard JG: Identification of an invasion-inducing gene,
Tiam-1, that encodes a protein with homology to GDP-GTP
exchangers for Rho-like proteins. Cell 1994, 77(4):537-549.
99. Marino N, Zollo M: Understanding h-prune biology in the fight
against cancer. Clin Exp Metastasis 2007, 24(8):637-645.
100. Otsuki Y, Tanaka M, Yoshii S, Kawazoe N, Nakaya K, Sugimura H:
Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by
interaction with Tiam1. Proc Natl Acad Sci U S A 2001,
98(8):4385-4390.
101. Reymond A, Volorio S, Merla G, Al-Maghtheh M, Zuffardi O, Bulfone A,
Ballabio A, Zollo M: Evidence for interaction between human PRUNE
and nm23-H1 NDPKinase. Oncogene 1999, 18(51):7244-7252.
102. Valentijn LJ, Koster J, Versteeg R: Read-through transcript from
NM23-H1 into the neighboring NM23-H2 gene encodes a novel
protein, NM23-LV. Genomics 2006, 87(4):483-489.
103. Ni X, Gu S, Dai J, Cheng H, Guo L, Li L, Ji C, Xie Y, Ying K, Mao Y:
Isolation and characterization of a novel human NM23-H1B gene, a
different transcript of NM23-H1. J Hum Genet 2003, 48(2):96-100.
104. Kristensen GB, Holm R, Abeler VM, Trope CG: Evaluation of the
prognostic significance of nm23/NDP kinase protein expression in
cervical carcinoma: an immunohistochemical study. Gynecol Oncol
1996, 61(3):378-383.
|